Olympia Diagnostics is an In Vitro Diagnostics (IVD) company focusing on development and commercialization of the most advanced breakthrough products for cancer diagnosis and prognosis.
Our mission is to create the most accurate and actionable diagnostic and prognostic products to improve cancer detection, diagnosis and treatment. We are dedicated to saving people’s lives, reducing patient suffering, lowering healthcare cost and burden to the society.
We have developed four novel IVD products to solve pressing problems of prostate cancer diagnosis and prognosis:
A quantitative diagnostic test for accurate detection and diagnosis of prostate cancer
A quantitative prognostic test for prediction of prostate cancer recurrence and patient survival
A quantitative prognostic test for accurate detection and prediction of prostate cancer metastasis
A quantitative diagnostic test for accurate detection of aggressive prostate cancer requiring treatment and indolent prostate cancer requiring surveillance